...
首页> 外文期刊>International journal of colorectal disease. >Rectal squamous cell carcinoma treated with chemoradiotherapy: report of six cases.
【24h】

Rectal squamous cell carcinoma treated with chemoradiotherapy: report of six cases.

机译:放化疗治疗直肠鳞状细胞癌6例报告。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Squamous cell carcinoma (SCC) of the colon and rectum is a rare pathologic entity. From May 2006 to August 2008 six consecutive patients with SCC of the rectum were treated at our institution. A retrospective analysis of these cases was performed in order to evaluate the role of chemoradiotherapy as an alternative to surgery. METHODS: All tumors were locally advanced and the clinical stage was T3N0M0 in three cases, T3N1M0, T4N1M0 and T3N2M1 in the other three cases. All patients received primary chemoradiation reserving surgery for unresponsive or recurrent tumors except in one of complete responders. Radiation treatment was given to standard pelvic volume up to 50.4 Gy in 28 fractions, with a boost to the primary tumor up to 59.4 Gy in two patients. RESULTS: A complete clinical response with a negative endoscopic biopsy was achieved in four patients and a partial response in two. Surgery as a part of the primary treatment was performed in the non-metastatic patient with partial response and in the first patient with complete response. At a median follow-up of 39 months (range, 24-41) from the end of chemoradiotherapy, five out of six patients remain alive and free of recurrence, three of them without having undergone surgery. CONCLUSION: Our data, though from a small series, give support to the hypothesis that concomitant chemoradiation may be considered a safe and effective therapeutic approach for patients with rectal SCC.
机译:目的:结肠和直肠的鳞状细胞癌(SCC)是一种罕见的病理学实体。从2006年5月至2008年8月,我们的机构连续治疗了6名直肠SCC患者。对这些病例进行回顾性分析,以评估放化疗替代手术的作用。方法:所有肿瘤均局部进展,三期为T3N0M0,其他三例为T3N1M0,T4N1M0和T3N2M1。除完全缓解者之一外,所有患者均因无反应或复发的肿瘤接受了原发性化学放疗手术。放射治疗的标准骨盆体积为28个部分,最高至50.4 Gy,其中两名患者的原发肿瘤增强至最高59.4 Gy。结果:4例患者获得了完整的临床反应,内镜活检阴性,其中2例得到了部分反应。在部分转移的非转移性患者和完全缓解的第一例患者中,手术是主要治疗的一部分。自放化疗结束后中位随访39个月(范围24-41),六分之五的患者仍然活着并且没有复发,其中三名未经手术治疗。结论:我们的数据尽管很小,但支持以下假设:伴随化学放疗可能被认为是直肠SCC患者的一种安全有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号